CreditReports.dk
HomeScreen companies

TCM Pharma ApS Financials, key figures and credit report

CVR number: 39022508 Established 2017 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Hestbækvej 93, Dollerup 9640 Farsø tel: 40411544
Gross profit 223.3 kDKK FY 2023 +40.5% vs 2022
EBIT 174.6 kDKK FY 2023 +275.9% vs 2022
Net debt 189.4 kDKK FY 2023 -81.3% vs 2022
Quick ratio 0.0 FY 2023 +0 vs 2022

Company information

Official name
TCM Pharma ApS
Personnel
1 person
Established
2017
Domicile
Dollerup
Company form
Private limited company
Industry

Data sources and methodology

The information about TCM Pharma ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2023.

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About TCM Pharma ApS

TCM Pharma ApS (CVR number: 3902250-8) is a company from VESTHIMMERLANDS. The company recorded a gross profit of 223.3 kDKK in 2023. The operating profit was 174.6 kDKK, while net earnings were 136.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was 20.2 %, which can be considered excellent and Return on Equity (ROE) was 27.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 10.6 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. TCM Pharma ApS's liquidity measured by quick ratio was 0 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2019
2020
2021
2022
2023
Volume
Net sales
Gross profit-16.5866.69458.27158.89223.31
EBIT- 122.66- 212.16174.83-99.27174.59
Net earnings- 113.84- 275.87133.62- 163.36136.38
Shareholders equity total-72.23- 348.10- 214.49- 283.0353.35
Balance sheet total (assets)1 344.071 081.911 284.86942.78503.22
Net debt1 312.461 336.511 385.271 013.04189.35
Profitability
EBIT-%
ROA-16.6 %-14.8 %11.9 %-7.3 %20.2 %
ROE-16.4 %-22.7 %11.3 %-14.7 %27.4 %
ROI-17.9 %-15.9 %12.8 %-8.2 %27.6 %
Economic value added (EVA)- 105.24- 282.70157.85- 108.85181.23
Solvency
Equity ratio-5.1 %-24.3 %-14.3 %-23.1 %10.6 %
Gearing-1 819.0 %- 384.0 %- 654.1 %- 358.0 %370.1 %
Relative net indebtedness %
Liquidity
Quick ratio0.10.00.50.00.0
Current ratio0.10.00.50.00.0
Cash and cash equivalents1.390.0917.720.108.11
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2023
20.2%
Rating 74/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2023
10.6%
Rating 11/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of TCM Pharma ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated